Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.890
+0.010 (0.53%)
At close: Oct 2, 2026, 4:00 PM EDT
1.860
-0.030 (-1.59%)
After-hours: Oct 2, 2026, 7:39 PM EDT
BDTX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| - | - | 70 | 70 | 70 | 70 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | 70 | 70 | 70 | 70 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selling, General & Admin | 16.43 | 15.86 | 16.57 | 15.64 | 20.26 | 25.73 | 27.47 | 27.06 | 29.7 | 27 | 27.11 | 28.79 | 27.21 | 27.31 | 28.39 | 27.56 | 29.03 | 30.04 | 30.04 | 29.05 |
Research & Development | 28.13 | 30.06 | 33.56 | 39.56 | 45.04 | 48.27 | 51.31 | 54.3 | 57.54 | 58.14 | 59.35 | 58.67 | 58.36 | 61.4 | 64.44 | 69.49 | 81.27 | 91.8 | 96.83 | 94.92 |
Operating Expenses | 44.56 | 45.92 | 50.13 | 55.2 | 65.3 | 74.01 | 78.78 | 81.36 | 87.24 | 85.15 | 86.46 | 87.46 | 85.57 | 88.71 | 92.83 | 97.06 | 110.3 | 121.84 | 126.87 | 123.98 |
Operating Income | -44.56 | -45.92 | 19.87 | 14.8 | 4.71 | -4.01 | -78.78 | -81.36 | -87.24 | -85.15 | -86.46 | -87.46 | -85.57 | -88.71 | -92.83 | -97.06 | -110.3 | -121.84 | -126.87 | -123.98 |
Interest & Investment Income | 4.29 | 4.49 | 4.06 | 3.44 | 2.79 | 2.14 | 2.18 | 1.94 | 1.86 | 1.94 | 1.92 | 2.28 | 2.4 | 2.25 | 2.03 | 1.94 | 2.16 | 2.72 | 3.46 | 4.13 |
Earnings From Equity Investments | - | - | - | - | - | - | - | - | - | - | - | -2.25 | -2.25 | -2.25 | -2.25 | - | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0 | -0 | 0.02 | -0 | 2.02 |
Other Non Operating Income (Expenses) | 4.28 | 4.29 | 4.51 | 4.34 | 4.36 | 4.11 | 3.14 | 2.45 | 1.49 | 1.2 | 0.92 | 0.81 | 0.73 | 0.36 | 0.18 | -0.01 | -0.01 | -0 | - | - |
EBT Excluding Unusual Items | -35.98 | -37.14 | 28.44 | 22.59 | 11.86 | 2.24 | -73.46 | -76.97 | -83.89 | -82.01 | -83.62 | -86.63 | -84.69 | -88.36 | -92.87 | -95.13 | -108.16 | -119.1 | -123.41 | -117.83 |
Merger & Restructuring Charges | - | - | - | -2.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gain (Loss) on Sale of Investments | 0.77 | 1.28 | 1.28 | 1.86 | 2.58 | 2.85 | 3.78 | 3.87 | 3.34 | 2.22 | 1.17 | 0.28 | -0.3 | -0.41 | -0.54 | -0.83 | -1.23 | -1.7 | -2.19 | -4.53 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | 2.23 | 2.23 | 2.23 | 2.23 | - | - | - | - | - |
Asset Writedown | -7.35 | -7.35 | -7.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -42.56 | -43.21 | 22.37 | 21.5 | 14.44 | 5.09 | -69.68 | -73.1 | -80.55 | -79.79 | -82.44 | -84.11 | -82.76 | -86.54 | -91.17 | -95.96 | -109.38 | -120.8 | -125.6 | -122.36 |
Net Income | -42.56 | -43.21 | 22.37 | 21.5 | 14.44 | 5.09 | -69.68 | -73.1 | -80.55 | -79.79 | -82.44 | -84.11 | -82.76 | -86.54 | -91.17 | -95.96 | -109.38 | -120.8 | -125.6 | -122.36 |
Net Income to Common | -42.56 | -43.21 | 22.37 | 21.5 | 14.44 | 5.09 | -69.68 | -73.1 | -80.55 | -79.79 | -82.44 | -84.11 | -82.76 | -86.54 | -91.17 | -95.96 | -109.38 | -120.8 | -125.6 | -122.36 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 57 | 57 | 57 | 57 | 57 | 56 | 55 | 54 | 52 | 48 | 44 | 40 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
Shares Outstanding (Diluted) | 57 | 57 | 58 | 57 | 57 | 56 | 55 | 54 | 52 | 48 | 44 | 40 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
Shares Change (YoY) | 0.22% | 0.91% | 4.61% | 6.44% | 8.73% | 18.22% | 25.19% | 34.09% | 43.95% | 31.36% | 21.00% | 10.58% | 0.50% | 0.42% | 0.38% | 0.40% | 0.48% | 0.59% | 9.97% | 47.94% |
EPS (Basic) | -0.74 | -0.76 | 0.39 | 0.38 | 0.25 | 0.09 | -1.27 | -1.36 | -1.54 | -1.67 | -1.88 | -2.10 | -2.27 | -2.38 | -2.51 | -2.64 | -3.02 | -3.33 | -3.47 | -3.39 |
EPS (Diluted) | -0.74 | -0.76 | 0.39 | 0.38 | 0.25 | 0.08 | -1.27 | -1.36 | -1.54 | -1.67 | -1.88 | -2.10 | -2.27 | -2.38 | -2.51 | -2.64 | -3.02 | -3.33 | -3.47 | -3.39 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -32.84 | -34.03 | 29.61 | 21.35 | 17.87 | 12.31 | -62.3 | -61.2 | -68.28 | -67.92 | -66.75 | -74.73 | -72.81 | -76.7 | -85.27 | -87.71 | -99.22 | -106.97 | -102.86 | -94.36 |
Free Cash Flow Per Share | -0.57 | -0.60 | 0.51 | 0.37 | 0.31 | 0.22 | -1.13 | -1.14 | -1.30 | -1.42 | -1.52 | -1.86 | -2.00 | -2.11 | -2.35 | -2.42 | -2.74 | -2.95 | -2.84 | -2.61 |
Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | 28.39% | 21.15% | 6.72% | -5.72% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit Margin | - | - | 31.95% | 30.71% | 20.63% | 7.27% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | 42.31% | 30.49% | 25.53% | 17.58% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | -44.35 | -45.65 | 20.2 | 15.15 | 5.05 | -3.66 | -78.44 | -81.02 | -86.87 | -84.74 | -86.02 | -86.98 | -85.08 | -88.21 | -92.32 | -96.55 | -109.88 | -121.53 | -126.67 | -123.88 |
EBITDA Margin | - | - | 28.85% | 21.64% | 7.21% | -5.23% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 0.21 | 0.27 | 0.33 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.37 | 0.4 | 0.44 | 0.48 | 0.49 | 0.51 | 0.51 | 0.51 | 0.42 | 0.31 | 0.21 | 0.1 |
EBIT | -44.56 | -45.92 | 19.87 | 14.8 | 4.71 | -4.01 | -78.78 | -81.36 | -87.24 | -85.15 | -86.46 | -87.46 | -85.57 | -88.71 | -92.83 | -97.06 | -110.3 | -121.84 | -126.87 | -123.98 |
EBIT Margin | - | - | 28.39% | 21.15% | 6.72% | -5.72% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |